NO20074523L - Overflate-lokaliserte Streptococcus pneumoniae polypeptider - Google Patents

Overflate-lokaliserte Streptococcus pneumoniae polypeptider

Info

Publication number
NO20074523L
NO20074523L NO20074523A NO20074523A NO20074523L NO 20074523 L NO20074523 L NO 20074523L NO 20074523 A NO20074523 A NO 20074523A NO 20074523 A NO20074523 A NO 20074523A NO 20074523 L NO20074523 L NO 20074523L
Authority
NO
Norway
Prior art keywords
localized
streptococcus pneumoniae
streptococcus
pneumoniae polypeptides
polypeptides
Prior art date
Application number
NO20074523A
Other languages
English (en)
Norwegian (no)
Inventor
Pia Nyborg Nielsen
Tatyana A Prokhorova
Petra Schrotz-King
Thomas Koefoed
Jorgen Petersen
Anders Boysen
Jens Sigh
Christian Morsczeck
Original Assignee
Ace Biosciences As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ace Biosciences As filed Critical Ace Biosciences As
Publication of NO20074523L publication Critical patent/NO20074523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO20074523A 2005-02-11 2007-09-05 Overflate-lokaliserte Streptococcus pneumoniae polypeptider NO20074523L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200500207 2005-02-11
US65393205P 2005-02-18 2005-02-18
DKPA200501194 2005-08-29
DKPA200501463 2005-10-18
PCT/DK2006/000073 WO2006084467A1 (en) 2005-02-11 2006-02-09 Surface-located streptococcus pneumoniae polypeptides

Publications (1)

Publication Number Publication Date
NO20074523L true NO20074523L (no) 2007-11-12

Family

ID=36588972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074523A NO20074523L (no) 2005-02-11 2007-09-05 Overflate-lokaliserte Streptococcus pneumoniae polypeptider

Country Status (8)

Country Link
US (1) US20090202528A1 (ja)
EP (1) EP1855717A4 (ja)
JP (1) JP2008530037A (ja)
KR (1) KR20070122458A (ja)
AU (1) AU2006212602A1 (ja)
CA (1) CA2597489A1 (ja)
NO (1) NO20074523L (ja)
WO (2) WO2006084466A2 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691243B2 (en) * 2002-04-02 2014-04-08 Ben-Gurion University Of The Negev Research And Development Authority Protein-based Streptococcus pneumoniae vaccine
EP3332791A1 (en) * 2007-03-05 2018-06-13 OM Pharma Bacterial extract for respiratory disorders and process for its preparation
WO2008119358A2 (en) * 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
US20100291024A1 (en) * 2007-03-30 2010-11-18 Xuebin Qin Methods and compositions for the treatment of proliferative and pathogenic diseases
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
EP2174664A1 (en) * 2008-10-07 2010-04-14 Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre New virulence factors of Streptococcus pneumoniae
JP5931724B2 (ja) * 2009-06-29 2016-06-08 ジェノセア バイオサイエンシーズ， インコーポレイテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物
EP3165531B1 (en) * 2010-03-12 2020-11-25 Children's Medical Center Corporation Immunogenic composition, vaccine, and uses thereof
EP2665490B1 (en) 2011-01-20 2020-03-04 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
EP2709603B1 (en) 2011-05-11 2021-03-24 Children's Medical Center Corporation Modified biotin-binding protein, fusion proteins thereof and applications
WO2013040648A1 (en) * 2011-09-23 2013-03-28 Adelaide Research & Innovation Pty Ltd Pneumococcal glpo immunogen
JP6379041B2 (ja) 2012-01-20 2018-08-22 ジェノセア バイオサイエンシーズ， インコーポレイテッド ストレプトコッカス・ニューモニエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）に対する融合抗原ワクチンおよび組成物
US11576958B2 (en) 2013-02-07 2023-02-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
EP3380118A4 (en) * 2015-11-25 2019-07-17 Wake Forest University Health Sciences PNEUMOKOK-DISABLED FACTOR COMPOSITIONS AND METHOD FOR USE THEREOF
US11103568B2 (en) 2016-04-05 2021-08-31 The Research Foundation For The State University Of New York Pneumococcal vaccine formulations
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN110730670A (zh) 2017-03-28 2020-01-24 儿童医疗中心有限公司 基于多抗原提呈系统(maps)的金黄色葡萄球菌疫苗、免疫原性组合物以及它们的用途
EP3641828B1 (en) 2017-06-23 2023-11-22 Affinivax, Inc. Immunogenic compositions
MX2020002556A (es) 2017-09-07 2020-07-13 Merck Sharp & Dohme Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
CN111630153A (zh) * 2018-01-22 2020-09-04 一般财团法人阪大微生物病研究会 用于培养肺炎球菌样品的培养基
KR20210093854A (ko) 2018-09-12 2021-07-28 아피니백스, 인크. 다가 폐렴구균 백신
WO2021010462A1 (ja) * 2019-07-17 2021-01-21 学校法人東日本学園 ベーチェット病の診断を補助する方法及び検査用キット

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696561B1 (en) * 1909-07-09 2004-02-24 Basf Aktiengesellschaft Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6583275B1 (en) * 1997-07-02 2003-06-24 Genome Therapeutics Corporation Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US5866369A (en) * 1997-09-18 1999-02-02 Smithkline Beecham Corporation Amps
US6562958B1 (en) * 1998-06-09 2003-05-13 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
US6822071B1 (en) * 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
US6544772B1 (en) * 2000-08-08 2003-04-08 Genesis Research & Development Corp. Ltd Polynucleotides, materials incorporating them, and methods for using them
US6764823B2 (en) * 2000-04-06 2004-07-20 Pharmacia & Upjohn Company Antimicrobial methods and materials
US6833447B1 (en) * 2000-07-10 2004-12-21 Monsanto Technology, Llc Myxococcus xanthus genome sequences and uses thereof
CN1361183A (zh) * 2000-12-25 2002-07-31 中国科学院长春应用化学研究所 多核α－双亚胺镍烯烃聚合催化剂
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
WO2002083855A2 (en) * 2001-04-16 2002-10-24 Wyeth Holdings Corporation Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
EP2275128B1 (en) * 2002-04-02 2013-10-16 Ben Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US7427408B2 (en) * 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation

Also Published As

Publication number Publication date
JP2008530037A (ja) 2008-08-07
WO2006084467A1 (en) 2006-08-17
WO2006084466A2 (en) 2006-08-17
KR20070122458A (ko) 2007-12-31
WO2006084466A3 (en) 2007-03-01
CA2597489A1 (en) 2006-08-17
US20090202528A1 (en) 2009-08-13
EP1855717A4 (en) 2009-12-23
AU2006212602A1 (en) 2006-08-17
EP1855717A1 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
NO20074523L (no) Overflate-lokaliserte Streptococcus pneumoniae polypeptider
NO20082531L (no) Neuropilinantagonister
BRPI0923649A2 (pt) polipeptídeos de pneumolisina (ply) de streptococcus pneumoniae modificados.
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
EA201301072A1 (ru) Антитела против il-23p19 и их применение
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
DE502006000512D1 (de) Tastenventil für medizinische Instrumente
AP2316A (en) Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same.
WO2005081908A3 (en) Reagents, kits and methods for immunodetection of epitopes on molecules
WO2008057777A3 (en) Oxygen sensors
DK1791958T3 (da) Gær/bakterie-to-hybridsystem og fremgangsmåder til brug deraf
NO20060777L (no) Muskarine acetylkolinreseptorantagonister
DE602006006976D1 (de) Festphasenoligosaccharid-tagging: eine technik zur manipulation immobilisierter kohlenhydrate
WO2009137138A3 (en) Methods of analyzing samples for bacteria using whole cell capture and atp analysis
DE602005005864D1 (de) Elastische Membran für einen Polierkopf sowie CMP-Vorrichtung, die diesen enthält
BRPI0520067A2 (pt) desenvolvimento de um ensaio de pcr em tempo real para a detecção de dna pneumocócico e diagnóstico da doença pneumocócica
DE602005023346D1 (de) Ausgangsbegrenzungseinrichtung für eine brennstoffzelle
EP1993601A4 (en) NON-SPRAYED PROTECTION REGIONS OF PNEUMOKOKEN SURFACES PSPA AND PSPC
HK1163113A1 (en) Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof psaa
DK1718340T3 (da) Nye effektorkonjugater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
EP2251035A3 (en) New virulence factors of Streptococcus pneumoniae
IL206437A0 (en) Assay for diagnosing streptococcus pneumoniae
JP2010526995A5 (ja)
WO2008041863A8 (en) Novel genes and polypeptides associated with insecticidal activity
IL186111A0 (en) Analysis methods for unmixing the response of non-linear, cross-reactive sensors and related system to single and multiple stimulants

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application